Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 PatientsMartin Spahn, Steven Joniau, Paolo Gontero et al.|European Urology|2010Cited by 154
Radical prostatectomy in very high-risk localized prostate cancer: Long-term outcomes and outcome predictorsSteven Joniau, Chao‐Yu Hsu, Paolo Gontero et al.|Scandinavian Journal of Urology and Nephrology|2012Cited by 48
Pretreatment Tables Predicting Pathologic Stage of Locally Advanced Prostate CancerSteven Joniau, Paolo Gontero, Burkhard Kneitz et al.|European Urology|2014Cited by 38
Is there a prostate‐specific antigen upper limit for radical prostatectomy?Paolo Gontero, Steven Joniau, Martin Spahn et al.|British Journal of Urology|2011Cited by 25
Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate CancerAlberto Martini, Alberto Briganti, Giorgio Gandaglia et al.|European Urology Oncology|2018Cited by 21